References: Nonspecific therapies for pulmonary hypertension

  • Bertoletti L, Mismetti V, Giannakoulas G. Use of Anticoagulants in Patients with Pulmonary Hypertension. Hamostaseologie 2020;40(3):348-55. https://www.ncbi.nlm.nih.gov/pubmed/32726829
  • Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016;37(1):67-119. https://www.ncbi.nlm.nih.gov/pubmed/26320113
  • Olsson KM, Delcroix M, Ghofrani HA, Tiede H, Huscher D, Speich R, et al. Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA). Circulation 2014;129(1):57-65. https://www.ncbi.nlm.nih.gov/pubmed/24081973
  • Rawal H, Suman A, Bhoite RR, Kanwal A, Young RK, Aronow WS, et al. Anticoagulation in Pulmonary Arterial Hypertension: Do We Know the Answer? Curr Probl Cardiol 2021;46(3):100738. https://www.ncbi.nlm.nih.gov/pubmed/33250263